Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like Innate Pharma Regroups From Trial Failure With €410 Million Deal For Novo Nordisk A/S's AntiC5aR Antibody June 4, 2017 Almac Diagnostics And EORTC Establish Collaboration For Tumor Molecular Profiling March 7, 2017 Spherix Announces The Addition Of To Company's Technology Advisory Board August 14, 2017
Innate Pharma Regroups From Trial Failure With €410 Million Deal For Novo Nordisk A/S's AntiC5aR Antibody June 4, 2017
